Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03714503 · ClinicalTrials.gov registry record · NA
Head Positioning After Retina Detachment Repair
A NA study of Retina; Detachment, Rhegmatogenous, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03714503: Recruiting NA study of Retina; Detachment, Rhegmatogenous, sponsored by University of Kansas Medical Center.
NCT03714503 is a NA study of Retina; Detachment, Rhegmatogenous that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03714503, a NA study of Retina; Detachment, Rhegmatogenous, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine if one day post-operative prone head positioning can be as good as seven days post-operative prone head positioning in patients with retinal detachments with inferior retinal breaks after pars that pars plana vitrectomy (PPV) using perfluoropropane (C3F8) gas as a tamponade. The investigator will conduct a single arm phase II study using a Simon's two-stage design
Primary Outcome
Retina remained attached on indirect ophthalmoscopy exam with scleral depression 360 degrees
Conditions Studied
Interventions
- DEVICE Retina re-attachment repair using C3F8 gas tamponade
Study Locations (1)
Kansas
- University of Kansas Medical Center - Prairie Village
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-04-08 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT03714503 shows while recruiting
NCT03714503 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Retina; Detachment, Rhegmatogenous appearing as the primary indexed condition, and to 1 intervention - of which Retina re-attachment repair using C3F8 gas tamponade is the first listed.
NCT03714503 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT03714503 about?
NCT03714503 is a clinical study titled "Head Positioning After Retina Detachment Repair". This study aims to determine if one day post-operative prone head positioning can be as good as seven days post-operative prone head positioning in patients with retinal detachments with inferior retinal breaks after pars that pars plana vitrectomy (PPV) using perfluoropropane (C3F8) gas as a tampon...
What is the current status of trial NCT03714503?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2019-04-08. Estimated completion is 2026-10.
What conditions does trial NCT03714503 study?
This clinical trial studies the following conditions: Retina; Detachment, Rhegmatogenous.
What interventions are being tested in trial NCT03714503?
The interventions under investigation include: Retina re-attachment repair using C3F8 gas tamponade (DEVICE).
Who is sponsoring clinical trial NCT03714503?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03714503 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03714503's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI